As of 2026-04-02, the EV/EBITDA ratio of BioNTech SE (BNTX) is -28.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BNTX's latest enterprise value is 15,025.54 mil USD. BNTX's TTM EBITDA according to its financial statements is -529.70 mil USD. Dividing these 2 quantities gives us the above BNTX EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 11.4x | 10.3x |
| Forward P/E multiples | 8.6x - 13.1x | 10.8x |
| Fair Price | 12.42 - 6.03 | 8.01 |
| Upside | -86.1% - -93.3% | -91.0% |
| Date | EV/EBITDA |
| 2026-04-01 | -24.64 |
| 2026-03-31 | -24.41 |
| 2026-03-30 | -22.84 |
| 2026-03-27 | -23.03 |
| 2026-03-26 | -23.79 |
| 2026-03-25 | -24.36 |
| 2026-03-24 | -23.51 |
| 2026-03-23 | -24.21 |
| 2026-03-20 | -24.58 |
| 2026-03-19 | -24.59 |
| 2026-03-18 | -24.89 |
| 2026-03-17 | -26.99 |
| 2026-03-16 | -25.13 |
| 2026-03-13 | -25.41 |
| 2026-03-12 | -24.94 |
| 2026-03-11 | -25.26 |
| 2026-03-10 | -22.25 |
| 2026-03-09 | -30.14 |
| 2026-03-06 | -29.86 |
| 2026-03-05 | -30.05 |
| 2026-03-04 | -30.85 |
| 2026-03-03 | -29.54 |
| 2026-03-02 | -32.44 |
| 2026-02-27 | -33.63 |
| 2026-02-26 | -33.01 |
| 2026-02-25 | -33.46 |
| 2026-02-24 | -33.91 |
| 2026-02-23 | -33.50 |
| 2026-02-20 | -33.59 |
| 2026-02-19 | -33.71 |
| 2026-02-18 | -32.65 |
| 2026-02-17 | -32.23 |
| 2026-02-13 | -31.75 |
| 2026-02-12 | -31.70 |
| 2026-02-11 | -33.26 |
| 2026-02-10 | -33.07 |
| 2026-02-09 | -33.68 |
| 2026-02-06 | -32.07 |
| 2026-02-05 | -31.61 |
| 2026-02-04 | -33.00 |
| 2026-02-03 | -32.78 |
| 2026-02-02 | -33.05 |
| 2026-01-30 | -35.15 |
| 2026-01-29 | -36.46 |
| 2026-01-28 | -36.19 |
| 2026-01-27 | -37.57 |
| 2026-01-26 | -36.99 |
| 2026-01-23 | -36.11 |
| 2026-01-22 | -37.19 |
| 2026-01-21 | -36.99 |